Lalwani Nikhil 4
4 · ANI PHARMACEUTICALS INC · Filed Mar 4, 2025
Insider Transaction Report
Form 4
Lalwani Nikhil
DirectorPRESIDENT & CEO
Transactions
- Tax Payment
Common Stock
2025-02-28$61.89/sh−12,216$756,048→ 502,694 total
Footnotes (1)
- [F1]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 23,882 shares of restricted stock, the grant of which was previously reported.